pharmaphorum November 28, 2023
It’s no secret that 2023 has been a year for a shift in thinking when it comes to psychedelics, in particular as pertains to their use for hard-to-treat or treatment resistant mental health disorders. As the field develops, however, it will be crucial to train the next generation of specialised therapists who possess the skillset to deliver such treatments to patients safely.
In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Sarah Bateup, therapy lead at Clerkenwell Health, a British start-up working to revolutionise the clinical research landscape by providing a holistic one-stop hub for drug development, trial design, and treatment delivery for complex mental health and neurological conditions – including psychedelic medicines and...
Today's Sponsors
Today's Sponsor